major glp 1 drugs The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications GLP-1 Medications for Weight Loss:

GLP-1 receptor agonists are not recommended in patients with a family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2A or 2B, due to an association between GLP-1 receptor agonists and benign and malignant thyroid C cell tumors in rodents [49]

Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy

Lower body weight reduces compressive force on the knees during walking and daily activity

Figure 4 Effects on Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS), which is mainly manifested as sparse ovulation or non-ovulation, high levels of androgens, ovarian polycystic changes, obesity, and infertility, is the most common endocrine and metabolic disorder in women of childbearing age (139)